Skip to content

Clinical trials

Completed Dyslipidemias trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Status: Completed Country / region: Netherlands Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20045
20055
200613
20071
20081
20091
20101
20113
20122
20133
20141
20162
20171
20203
20212
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed48

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda9
Kowa Research Europe8
Amgen4
Maastricht University Medical Center3
NewAmsterdam Pharma3
Akros Pharma Inc.2
Amarin Pharma Inc.2
AstraZeneca2
Eli Lilly and Company2
Kastle Therapeutics, LLC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias48
Hypercholesterolemia16
Diabetes Mellitus, Type 210
Hyperlipidemias9
Diabetes Mellitus8
Glucose Metabolism Disorders8
Atherosclerosis6
Cardiovascular Diseases6
Hypertriglyceridemia4
Lipid Metabolism Disorders4

Trials

Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.